Foghorn Therapeutics Inc. (FHTX) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 68.08M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $68.08M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $87.66M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $80.88M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $89.33M | (m) | (m) |
| 2025-06-30 | (m) | (m) | $72.57M | (m) | (m) |
| 2025-03-31 | (m) | (m) | $61.03M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $55.45M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $57.68M | (m) | (m) |
| 2024-06-30 | (m) | (m) | $138.95M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $79.25M | (m) | (m) |
| 2023-12-31 | (m) | (m) | $80.34M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $70.31M | (m) | (m) |
| 2023-06-30 | (m) | (m) | $57.70M | (m) | (m) |
| 2023-03-31 | (m) | (m) | $50.64M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $52.21M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $87.60M | (m) | (m) |
| 2022-06-30 | (m) | (m) | $61.21M | (m) | (m) |
| 2022-03-31 | (m) | (m) | $213.65M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $101.14M | (m) | (m) |
| 2021-09-30 | (m) | (m) | $57.84M | (m) | (m) |
| 2021-06-30 | (m) | (m) | $125.17M | (m) | (m) |
| 2021-03-31 | (m) | (m) | $66.45M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $92.80M | (m) | (m) |
| 2020-09-30 | (m) | (m) | $74.62M | (m) | (m) |
| 2020-06-30 | (m) | (m) | $36.56M | (m) | (m) |
| 2020-03-31 | (m) | (m) | $3.44M | (m) | (m) |
| 2019-12-31 | (m) | (m) | $14.98M | (m) | (m) |
| 2019-09-30 | (m) | (m) | $21.50M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |